Browse > Article
http://dx.doi.org/10.3340/jkns.2013.54.5.426

Rapid Progression of Solitary Plasmacytoma to Multiple Myeloma in Lumbar Vertebra  

Yang, Jin Seo (Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University)
Cho, Yong Jun (Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University)
Kang, Suk Hyung (Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University)
Choi, Hyuk Jai (Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University)
Publication Information
Journal of Korean Neurosurgical Society / v.54, no.5, 2013 , pp. 426-430 More about this Journal
Abstract
The prognosis of solitary plasmacytoma varies greatly, with some patients recovering after surgical removal or local fractional radiation therapy, and others progressing to multiple myeloma years later. Primary detection of progression to multiple myeloma is important in the treatment of solitary plasmacytoma. There have been several analyses of the risk factors involved in the early progression to multiple myeloma. We describe one case of solitary plasmacytoma of the lumbar vertebra that was treated with surgical decompression with stabilization and additional radiotherapy. The patient had no factors associated with rapid progression to multiple myeloma such as age, size, immunologic results, pathological findings, and serum free light chain ratio at the time of diagnosis. However, his condition progressed to multiple myeloma less than two months after the initial diagnosis of solitary plasmacytoma. We suggest that surgeons should be vigilant in watching for rapid progression to multiple myeloma even in case that the patient with solitary plasmacytoma has no risk factors for rapid progression to multiple myeloma.
Keywords
Solitary plasmacytoma; Serum free light chain; Multiple myeloma; Lumbar vertebrae;
Citations & Related Records
연도 인용수 순위
  • Reference
1 van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coffey JC, van Egmond M : The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 249 : 727-734, 2009   DOI   ScienceOn
2 Wilder RB, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R : Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer 94 : 1532-1537, 2002   DOI   ScienceOn
3 Zazpe I, Caballero C, Cabada T, Guerrero D, Gallo-Ruiz A, Portillo E : Solitary thoracic intradural extramedullary plasmacytoma. Acta Neurochir (Wien) 149 : 529-532; discussion 532, 2007   DOI
4 Knowling MA, Harwood AR, Bergsagel DE : Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1 : 255-262, 1983   DOI
5 Kumar S : Solitary plasmacytoma : is radiation therapy sufficient? Am J Hematol 83 : 695-696, 2008   DOI   ScienceOn
6 Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Wellik L, et al. : Prognostic value of angiogenesis in solitary bone plasmacytoma. Blood 101 : 1715-1717, 2003   DOI   ScienceOn
7 Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R : Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol 52 : 245-249, 1999   DOI   ScienceOn
8 Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R : Solitary bone plasmacytoma : outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 41 : 1063-1067, 1998   DOI   ScienceOn
9 Liu HY, Luo XM, Zhou SH, Zheng ZJ : Prognosis and expression of lambda light chains in solitary extramedullary plasmacytoma of the head and neck : two case reports and a literature review. J Int Med Res 38 : 282-288, 2010   DOI
10 Mayr NA, Wen BC, Hussey DH, Burns CP, Staples JJ, Doornbos JF, et al. : The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 17 : 293-303, 1990   DOI   ScienceOn
11 Mendoza S, Urrutia J, Fuentes D : Surgical treatment of solitary plasmocytoma of the spine : case series. Iowa Orthop J 24 : 86-94, 2004
12 Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, et al. : Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 106 : 812-817, 2005   DOI   ScienceOn
13 Snozek CL, Katzmann JA, Kyle RA, Dispenzieri A, Larson DR, Therneau TM, et al. : Prognostic value of the serum free light chain ratio in newly diagnosed myeloma : proposed incorporation into the international staging system. Leukemia 22 : 1933-1937, 2008   DOI   ScienceOn
14 Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. : Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 16 : 405-413, 2004   DOI   ScienceOn
15 Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R : Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 96 : 2037-2044, 2000
16 Kilciksiz S, Celik OK, Pak Y, Demiral AN, Pehlivan M, Orhan O, et al. : Clinical and prognostic features of plasmacytomas : a multicenter study of Turkish Oncology Group-Sarcoma Working Party. Am J Hematol 83 : 702-707, 2008   DOI   ScienceOn
17 Brivio F, Gilardi R, Bucocev R, Ferrante R, Rescaldani R, Vigore L, et al. : Surgery-induced decline in circulating dendritic cells in operable cancer patients : a possible explanation of postoperative immunosuppression. Hepatogastroenterology 47 : 1337-1339, 2000
18 Cappuccio M, De Iure F, Gasbarrini A, Bandiera S, Boriani S : Solitary plasmacytoma of the spine : a 22 years follow-up case report. Eur Rev Med Pharmacol Sci 10 : 251-256, 2006
19 Chakraborti C, Miller KL : Multiple myeloma presenting as spinal cord compression: a case report. J Med Case Rep 4 : 251, 2010   DOI   ScienceOn
20 Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A, et al. : Consensus recommendations for standard investigative workup : report of the International Myeloma Workshop Consensus Panel 3. Blood 117 : 4701-4705, 2011   DOI   ScienceOn
21 Dingli D, Kyle RA, Rajkumar SV, Nowakowski GS, Larson DR, Bida JP, et al. : Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 108 : 1979-1983, 2006   DOI   ScienceOn
22 Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA : Solitary plasmacytoma of bone : Mayo Clinic experience. Int J Radiat Oncol Biol Phys 16 : 43-48, 1989   DOI   ScienceOn
23 Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J, et al. : International staging system for multiple myeloma. J Clin Oncol 23 : 3412-3420, 2005   DOI   ScienceOn
24 Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA : Surgery induced immunosuppression. Surgeon 9 : 38-43, 2011   DOI   ScienceOn
25 Holland J, Trenkner DA, Wasserman TH, Fineberg B : Plasmacytoma. Treatment results and conversion to myeloma. Cancer 69 : 1513-1517, 1992   DOI   ScienceOn
26 Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. : Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 124 : 717-726, 2004   DOI   ScienceOn
27 Bertanha F, Boufelli G, de Camargo OP, Baptista AM, Caiero MT, de Oliveira CR, et al. : Oncologic progression of bone plasmacytomas to multiple myeloma. Clinics (Sao Paulo) 61 : 139-146, 2006
28 Terszowski G, Passweg JR, Stern M : Natural killer cell immunity after transplantation. Swiss Med Wkly 142 : w13700, 2012
29 Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. : Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 50 : 113-210, 2001   DOI   ScienceOn
30 Knobel D, Zouhair A, Tsang RW, Poortmans P, Belkacemi Y, Bolla M, et al. : Prognostic factors in solitary plasmacytoma of the bone : a multicenter Rare Cancer Network study. BMC Cancer 6 : 118, 2006   DOI